Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
75,492,617
-
Share change
-
-7,181
-
Total reported value
-
$810,596,588
-
Put/Call ratio
-
56%
-
Price per share
-
$10.74
-
Number of holders
-
121
-
Value change
-
-$14,666,450
-
Number of buys
-
67
-
Number of sells
-
55
Institutional Holders of TRILLIUM THERAPEUTICS INC - COM NEW as of Q1 2021
As of 31 Mar 2021,
TRILLIUM THERAPEUTICS INC - COM NEW was held by
121 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
75,492,617 shares.
The largest 10 holders included
EVENTIDE ASSET MANAGEMENT, LLC, NEA Management Company, LLC, Avoro Capital Advisors LLC, RA CAPITAL MANAGEMENT, L.P., VR Adviser, LLC, Avidity Partners Management LP, CITADEL ADVISORS LLC, FRANKLIN RESOURCES INC, ORBIMED ADVISORS LLC, and FRAZIER MANAGEMENT LLC.
This page lists
121
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.